216 related articles for article (PubMed ID: 26083313)
1. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.
Harrison VS; Carney CE; MacRenaris KW; Waters EA; Meade TJ
J Am Chem Soc; 2015 Jul; 137(28):9108-16. PubMed ID: 26083313
[TBL] [Abstract][Full Text] [Related]
2. A multimeric MR-optical contrast agent for multimodal imaging.
Harrison VS; Carney CE; Macrenaris KW; Meade TJ
Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290
[TBL] [Abstract][Full Text] [Related]
3. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
5. Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging.
Carney CE; Lenov IL; Baker CJ; MacRenaris KW; Eckermann AL; Sligar SG; Meade TJ
Bioconjug Chem; 2015 May; 26(5):899-905. PubMed ID: 25830565
[TBL] [Abstract][Full Text] [Related]
6. Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.
Ferreira MF; Gonçalves J; Mousavi B; Prata MI; Rodrigues SP; Calle D; López-Larrubia P; Cerdan S; Rodrigues TB; Ferreira PM; Helm L; Martins JA; Geraldes CF
Dalton Trans; 2015 Mar; 44(9):4016-31. PubMed ID: 25611006
[TBL] [Abstract][Full Text] [Related]
7. Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.
Yang W; Guo W; Gong X; Zhang B; Wang S; Chen N; Yang W; Tu Y; Fang X; Chang J
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18759-68. PubMed ID: 26257133
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.
Vivero-Escoto JL; Taylor-Pashow KM; Huxford RC; Della Rocca J; Okoruwa C; An H; Lin W; Lin W
Small; 2011 Dec; 7(24):3519-28. PubMed ID: 22069305
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent.
Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y
J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
[TBL] [Abstract][Full Text] [Related]
11. Bioresponsive, cell-penetrating, and multimeric MR contrast agents.
Major JL; Meade TJ
Acc Chem Res; 2009 Jul; 42(7):893-903. PubMed ID: 19537782
[TBL] [Abstract][Full Text] [Related]
12. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
13. Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence.
Endres PJ; Macrenaris KW; Vogt S; Allen MJ; Meade TJ
Mol Imaging; 2006; 5(4):485-97. PubMed ID: 17150161
[TBL] [Abstract][Full Text] [Related]
14. Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications.
Vojtech JM; Cano-Mejia J; Dumont MF; Sze RW; Fernandes R
J Vis Exp; 2015 Apr; (98):e52621. PubMed ID: 25993028
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Magnetic Gd(3+) -Based Coordination Polymer Nanoparticles: Combination of Magnetic Resonance and Multispectral Optoacoustic Detections for Tumor-Targeted Imaging in vivo.
An Q; Liu J; Yu M; Wan J; Li D; Wang C; Chen C; Guo J
Small; 2015 Nov; 11(42):5675-86. PubMed ID: 26366746
[TBL] [Abstract][Full Text] [Related]
16. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
Gugliotta G; Botta M; Tei L
Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
[TBL] [Abstract][Full Text] [Related]
17. Tetranuclear gadolinium(III) porphyrin complex as a theranostic agent for multimodal imaging and photodynamic therapy.
Luo J; Chen LF; Hu P; Chen ZN
Inorg Chem; 2014 Apr; 53(8):4184-91. PubMed ID: 24693998
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Jin Y; Wang K; Tian J
Bioconjug Chem; 2018 Apr; 29(4):1475-1484. PubMed ID: 29544252
[TBL] [Abstract][Full Text] [Related]
19. PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity.
Liu Z; Pu F; Liu J; Jiang L; Yuan Q; Li Z; Ren J; Qu X
Nanoscale; 2013 May; 5(10):4252-61. PubMed ID: 23546530
[TBL] [Abstract][Full Text] [Related]
20. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
